M&A Deal Summary

Genovac Acquires Carterra LSA Instrument

On April 20, 2022, Genovac acquired life science company Carterra LSA Instrument from Carterra

Acquisition Highlights
  • This is Genovac’s 1st transaction in the Life Science sector.
  • This is Genovac’s 1st transaction in the United States.
  • This is Genovac’s 1st transaction in Utah.

M&A Deal Summary
Date 2022-04-20
Target Carterra LSA Instrument
Sector Life Science
Buyer(s) Genovac
Sellers(s) Carterra
Deal Type Divestiture

Target

Carterra LSA Instrument

Salt Lake City, Utah, United States
Carterra LSA Instrument provides an antibody discovery and characterization platform utilizing Surface Plasmon Resonance (HT-SPR) technology and has quickly made it the standard in 16 of the largest 20 pharmaceutical companies, biotechs, CROs, and government labs.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Genovac

Freiburg, Germany
Category Company
Founded 1999
Sector Life Science
DESCRIPTION

Genovac is a contract research and manufacturing organization offering advanced antibody discovery solutions. Its immunization technologies, combined with multiple single-cell screening technologies, including Berkeley Lights’ Beacon, enable success against the most challenging targets. Genovac was founded in 1999 and is based in Freiburg, Germany.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (Utah) 1 of 1
Country (United States) 1 of 1
Year (2022) 1 of 1

Seller(S) 1

SELLER

Carterra

Salt Lake City, Utah, United States
Category Company
Founded 2005
Sector Medical Products
DESCRIPTION

Carterra is a provider of innovative technologies designed to accelerate the discovery of novel therapeutic candidates. Carterra’s high throughput LSA™ instrument for monoclonal antibody (mAb) screening and characterization combines patented microfluidics technology with real-time High Throughput Surface Plasmon Resonance (HT-SPR) and industry-leading Kinetic and Epitope analysis and visualization software, delivering up to 100 times the throughput in 10% of the time while using only 1% of the sample compared to existing platforms. Carterra was founded in 2005 and is based in Salt Lake City, Utah.

DEAL STATS #
Overall 1 of 2
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 2
State (Utah) 1 of 2
Country (United States) 1 of 2
Year (2022) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-03-20 Carterra s LSA Instrument

Salt Lake City, Utah, United States

Carterra's LSA Instrument which allows for high throughput surface plasmon resonance-based antibody characterizations thereby significantly increasing the Company’s capacity in performing various label-free protein interaction analyses including best-in-class kinetics, epitope binning, quantitation, epitope mapping, and blocking/neutralization assays.

Sell -
Mergr

Product

Company

Legal